263 related articles for article (PubMed ID: 24872809)
1. Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.
Zhang Y; Jiao J; Yang P; Lu H
Clin Proteomics; 2014; 11(1):18. PubMed ID: 24872809
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
3. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
4. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
Wessels HJCT; Kulkarni P; van Dael M; Suppers A; Willems E; Zijlstra F; Kragt E; Gloerich J; Schmit PO; Pengelley S; Marx K; van Gool AJ; Lefeber DJ
J Adv Res; 2024 Jul; 61():179-192. PubMed ID: 37683725
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.
Chen Z; Huang J; Li L
Trends Analyt Chem; 2019 Sep; 118():880-892. PubMed ID: 31579312
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry based glycoproteomics--from a proteomics perspective.
Pan S; Chen R; Aebersold R; Brentnall TA
Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
[TBL] [Abstract][Full Text] [Related]
8. Technologies and strategies for glycoproteomics and glycomics and their application to clinical biomarker research.
Tousi F; Hancock WS; Hincapie M
Anal Methods; 2011 Jan; 3(1):20-32. PubMed ID: 32938106
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review.
Zhong L; Zhu L; Cai ZW
J Anal Test; 2021; 5(4):298-313. PubMed ID: 34513131
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive, Open-source Platform for Mass Spectrometry-based Glycoproteomics Data Analysis.
Liu G; Cheng K; Lo CY; Li J; Qu J; Neelamegham S
Mol Cell Proteomics; 2017 Nov; 16(11):2032-2047. PubMed ID: 28887379
[TBL] [Abstract][Full Text] [Related]
11. Current Technologies for Complex Glycoproteomics and Their Applications to Biology/Disease-Driven Glycoproteomics.
Narimatsu H; Kaji H; Vakhrushev SY; Clausen H; Zhang H; Noro E; Togayachi A; Nagai-Okatani C; Kuno A; Zou X; Cheng L; Tao SC; Sun Y
J Proteome Res; 2018 Dec; 17(12):4097-4112. PubMed ID: 30359034
[TBL] [Abstract][Full Text] [Related]
12. Strategies for Proteome-Wide Quantification of Glycosylation Macro- and Micro-Heterogeneity.
Fang P; Ji Y; Oellerich T; Urlaub H; Pan KT
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163546
[TBL] [Abstract][Full Text] [Related]
13. Robust Glycoproteomics Platform Reveals a Tetra-Antennary Site-Specific Glycan Capping with Sialyl-Lewis Antigen for Early Detection of Gastric Cancer.
Liu L; Liu L; Wang Y; Fang Z; Bian Y; Zhang W; Wang Z; Gao X; Zhao C; Tian M; Liu X; Qin H; Guo Z; Liang X; Dong M; Nie Y; Ye M
Adv Sci (Weinh); 2024 Mar; 11(9):e2306955. PubMed ID: 38084450
[TBL] [Abstract][Full Text] [Related]
14. Glycoproteomics: growing up fast.
Thomas DR; Scott NE
Curr Opin Struct Biol; 2021 Jun; 68():18-25. PubMed ID: 33278752
[TBL] [Abstract][Full Text] [Related]
15. Label-free glycopeptide quantification for biomarker discovery in human sera.
Mayampurath A; Song E; Mathur A; Yu CY; Hammoud Z; Mechref Y; Tang H
J Proteome Res; 2014 Nov; 13(11):4821-32. PubMed ID: 24946017
[TBL] [Abstract][Full Text] [Related]
16. Toward Automated N-Glycopeptide Identification in Glycoproteomics.
Lee LY; Moh ES; Parker BL; Bern M; Packer NH; Thaysen-Andersen M
J Proteome Res; 2016 Oct; 15(10):3904-3915. PubMed ID: 27519006
[TBL] [Abstract][Full Text] [Related]
17. Advances in mass spectrometry-based glycoproteomics: An update covering the period 2017-2021.
Gutierrez-Reyes CD; Jiang P; Atashi M; Bennett A; Yu A; Peng W; Zhong J; Mechref Y
Electrophoresis; 2022 Jan; 43(1-2):370-387. PubMed ID: 34614238
[TBL] [Abstract][Full Text] [Related]
18. In silico approaches for unveiling novel glycobiomarkers in cancer.
Azevedo R; Silva AMN; Reis CA; Santos LL; Ferreira JA
J Proteomics; 2018 Jan; 171():95-106. PubMed ID: 28782717
[TBL] [Abstract][Full Text] [Related]
19. Towards structure-focused glycoproteomics.
Chernykh A; Kawahara R; Thaysen-Andersen M
Biochem Soc Trans; 2021 Feb; 49(1):161-186. PubMed ID: 33439247
[TBL] [Abstract][Full Text] [Related]
20. Exploration of quantitative site-specific serum O-glycoproteomics with isobaric labeling for the discovery of putative O-glycoprotein biomarkers.
Zhang Z; Xu H; Tian Z
Proteomics Clin Appl; 2022 Nov; 16(6):e2100095. PubMed ID: 35507764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
